One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome
about
What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patientsThe role of microbial biofilms in prosthetic joint infectionsTreatment of acute periprosthetic infections with prosthesis retention: Review of current conceptsOne-stage or two-stage revision surgery for prosthetic hip joint infection--the INFORM trial: a study protocol for a randomised controlled trial.Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?Biofilm Disrupting Technology for Orthopedic Implants: What's on the Horizon?Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant.Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology.Revision for prosthetic joint infection following hip arthroplasty: Evidence from the National Joint RegistryLate Periprosthetic Joint Infection due to Staphylococcus lugdunensis Identified by Matrix-Assisted Laser Desorption/Ionisation Time of Flight Mass Spectrometry: A Case Report and Review of the Literature.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort studyStaphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.A systematic review of the evidence for single stage and two stage revision of infected knee replacement.Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureusSurgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register.75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections.Prosthetic joint infections.Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapyTREATMENT OF INFECTION AFTER TOTAL KNEE ARTHROPLASTYDaptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) databaseProsthesis infections after orthopedic joint replacement: the possible role of bacterial biofilmsRevision in cemented and cementless infected hip arthroplasty.Pathogen-driven decision for implant retention in the management of infected total knee prostheses.Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients.Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infectionsRole of Suppressive Oral Antibiotics in Orthopedic Hardware Infections for Those Not Undergoing Two-Stage Replacement Surgery.Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.Aggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements.The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement - a literature reviewInfection in total hip replacement: meta-analysisProsthetic joint infection: diagnosis and management.Current concepts in the management of prosthetic joint infection.Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.A Review of the Literature on Culture-Negative Periprosthetic Joint Infection: Epidemiology, Diagnosis and Treatment.Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review.Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.One-stage versus two-stage exchange arthroplasty for infected total knee arthroplasty: a systematic review.What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature.Description of the rates, trends and surgical burden associated with revision for prosthetic joint infection following primary and revision knee replacements in England and Wales: an analysis of the National Joint Registry for England, Wales, Northe
P2860
Q26851302-CD349F39-34F7-4463-84EB-CD1806CB49BAQ27021270-B48F6425-90B3-4725-9941-112346F49090Q27022797-08C3622C-36CB-48E5-AA91-23490B22BD4EQ27334520-19839203-EE2B-4AE9-9A2B-9A332136F9E0Q28071834-D13D3C86-D1CD-4E48-8E7A-FC82636B3C4EQ28083459-4CB371E4-16D5-4509-AD14-5162AD86A4DAQ33395850-B7E9AA6A-DB35-4F11-B9E8-5EE374311314Q33636212-23910868-F981-4750-B091-FDBEC4E2D226Q33856978-2A15EF31-AD74-4E76-B817-36DDB9F9822EQ33966911-DA5B90C4-E699-48C9-BB9E-38786E066601Q34100226-373524E7-5C73-4418-AABE-4D7D006E6FDCQ34478074-1E3424C1-618F-495A-BFED-824A2CF46622Q34878235-A9EE7299-BF15-4A99-BCB8-636EBC716A32Q35598090-E0DFD083-2842-453C-B4DB-A0D5194E7415Q35624399-10B798EE-820C-4CA4-9587-D7BBFDAFE3DAQ35885266-A2558CBC-BA0C-4D92-981C-0D9CC780B914Q36206844-0AC3A688-DF05-47BC-AB17-C0E05AAC81E5Q36505327-3344B98C-68F0-4A5F-8130-015CBF4EAD23Q36643154-52390E24-0B0C-48F1-8CFE-54C5A7D7836CQ36929393-ECAE4BE9-CD76-4BDA-A0AF-370F6BCEC777Q37032050-D0C438EB-0F6C-49C8-B8BB-A9C64D228743Q37043516-3B3A0722-1922-4D31-8558-C6F2D91B1176Q37057488-6D8909B2-BBFB-43E1-9E68-974A2B94134CQ37158397-8BF3A808-276E-4D8B-B771-466DCADD51BAQ37202102-DDB76DD1-A52F-4305-A97F-13E1885D45E0Q37338078-EC4F09C6-546B-47E8-B637-95A81CB8812EQ37544629-07675D68-BE58-4969-8335-112160803A8FQ37570739-C4F5B0C2-FD4A-4C88-BD51-AE5C8D2B8531Q37579464-45771E3E-402E-4878-9EC5-A41500253746Q37810488-41F72863-6D4C-4217-92C7-26F57FCBD975Q37929757-4D5392EB-153F-4C3B-BFF8-84C90B4DE112Q38221335-1664224A-078C-484F-A600-E2B9DD87CBA0Q38230862-2053A1C3-3529-4F68-A0DF-B64DF8EBB563Q38314400-20AED05B-E147-48C4-BC2F-43D8E12DCEDBQ38399139-819197B1-139C-4457-B563-3D59D56C2AD8Q38450497-57C66F6F-3BF3-4435-87A7-D2784D32ADADQ38490164-D5B34ADB-D8B1-47B8-8D08-F9DAEF751162Q38590757-7394CE96-0BA0-4416-933F-EA4A77CD323FQ38649627-032F4A79-582A-455C-8435-9DE762634168Q38658953-A6F40CA7-C137-476B-830D-081EF57313F3
P2860
One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
One hundred and twelve infecte ...... ntibiotic duration and outcome
@en
One hundred and twelve infecte ...... tibiotic duration and outcome.
@nl
type
label
One hundred and twelve infecte ...... ntibiotic duration and outcome
@en
One hundred and twelve infecte ...... tibiotic duration and outcome.
@nl
prefLabel
One hundred and twelve infecte ...... ntibiotic duration and outcome
@en
One hundred and twelve infecte ...... tibiotic duration and outcome.
@nl
P2093
P2860
P356
P1476
One hundred and twelve infecte ...... ntibiotic duration and outcome
@en
P2093
B L Atkins
P McLardy-Smith
P2860
P304
P356
10.1093/JAC/DKP107
P407
P577
2009-03-31T00:00:00Z